Antibodies to human TIE-2 ligands

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303871, 5303881, 53038823, 53038824, 5303891, 5303892, C07K 1618, C07K 1622, C07K 1624

Patent

active

061661856

ABSTRACT:
The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE-2 receptor, a method of blocking the growth or differentiation of a cell expressing the TIE-2 receptor and a method of attenuating or preventing tumor growth in a human.

REFERENCES:
Harlow et al. (1988) Antibodies `A Laboratory Manual`. Cold Spring Harbor Laboratory p. 76, Chapter 5.
Lerner (1982) Native vol. 299 pp. 592-596.
Nomura et al. (1994) DNA Research vol. 1, Supplement, pp. 47-56.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies to human TIE-2 ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to human TIE-2 ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human TIE-2 ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-996325

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.